![]() |
|
|
Vol. 27, Issue 1, 81-85, January 1999
Service de néphrologie, Hopital Maisonneuve-Rosemont and
Département de Pharmacologie, Faculté de Médecine,
Université de Montréal
To investigate the influence of furosemide plasma protein binding
on its kinetics and dynamics, the kinetics of furosemide was studied in
the presence of a protein binding displacer, warfarin, and in
hypoalbuminemic rabbits. Compared with controls, in anesthetized rabbits pretreated with warfarin, the unbound fraction of furosemide increased from 1.8 ± 0.4% to 7.0 ± 0.4%
(p < .001), and its metabolic clearance
increased by 30%, whereas furosemide urinary excretion decreased by
48% (p < .05). Experiments in nephrectomized
rabbits showed that the increase in metabolic clearance was
secondary to an increase in its renal metabolic clearance
(p < .05). Compared with controls, in warfarin
pretreated rabbits, sodium excretion and diuresis were decreased by
30% (p < .05). However, when furosemide was
injected mixed with albumin, warfarin-induced kinetic and dynamic
alterations of furosemide were reversed. Compared with control rabbits,
in conscious hypoalbuminemic rabbits, furosemide unbound fraction was
enhanced from 1.2 ± 0.1% to 5.5 ± 0.5%
(p < .001), and its urinary excretion, diuresis,
and sodium excretion were reduced by 22% (p < .05). The administration of warfarin to hypoalbuminemic rabbits further
increased the fraction of unbound furosemide, and diminished its
urinary excretion and diuretic effect. In conclusion, 1) binding of
furosemide to plasma proteins, and not albumin per se, facilitates its
renal secretion and pharmacological response; 2) the decrease in
furosemide binding, secondary to drug displacement and/or
hypoalbuminemia, can be a cause of resistance to the diuretic; and 3)
when furosemide binding is decreased, the administration of furosemide
mixed with albumin enhances its renal secretion and diuretic effect.
This article has been cited by other articles:
![]() |
F. Cavaliere, G. Conti, U. Moscato, F. Meo, M. A. Pennisi, R. Costa, and R. Proietti Hypoalbuminaemia does not impair Diprifusor performance during sedation with propofol Br. J. Anaesth., April 1, 2005; 94(4): 453 - 458. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Wilcox New Insights into Diuretic Use in Patients with Chronic Renal Disease J. Am. Soc. Nephrol., March 1, 2002; 13(3): 798 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Castaneda-Hernandez, J. Verges, V. Pichette, L. Heroux, G. Caille, and P. du Souich Input Rate as a Major Determinant of Furosemide Pharmacodynamics: Influence of Fluid Replacement and Hypoalbuminemia Drug Metab. Dispos., March 1, 2000; 28(3): 323 - 328. [Abstract] [Full Text] [PDF] |
||||